EDGAR Filing Documents for 0001129928-15-000002

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001129928-15-000002

Filing Date

2015-03-20

Accepted

2015-03-19 18:55:40

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	2014 FORM 20-F	oncy2014-20f.htm	20-F	1771517
2	AMENDMENT - TUCHMAN	ex427amendment-tuchman.htm	EX-4.27	13794
3	AMENDMENT - DILLAHUNTY	ex428amendment-dillahunty.htm	EX-4.28	13631
4	AMENDMENT - THOMPSON	ex429amendment-thompson.htm	EX-4.29	13820
5	AMENDMENT - GILL	ex430amendment-gill.htm	EX-4.30	13783
6	AMENDMENT - LOOK	ex431amendment-look.htm	EX-4.31	13727
7	AMENDMENT - COFFEY	ex432amendment-coffey.htm	EX-4.32	13666
8	SUBSIDIARIES	ex80listofsubsidiaries.htm	EX-8.0	4961
9	CEO CERTIFICATION	ex121ceocertification.htm	EX-12.1	13542
10	CFO CERTIFICATION	ex122cfocertification.htm	EX-12.2	12638
11	CEO CERTIFICATION	ex131ceocertification.htm	EX-13.1	6991
12	CFO CERTIFICATION	ex132cfocertification.htm	EX-13.2	5830
13	2014 MD&A	ex151-2014mda.htm	EX-15.1	428942
14	EY CONSENT	ex152eyconsentletter.htm	EX-15.2	4901
15		image1.jpg	GRAPHIC	86821
16		image3.jpg	GRAPHIC	6545
17		image4.jpg	GRAPHIC	32654
	Complete submission text file	0001129928-15-000002.txt		2506732

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7

Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380

ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-31062 | Film No.: 15714105
SIC: 2834 Pharmaceutical Preparations